Here's Why Structure Therapeutics (GPCR) Fell in Q4 [Yahoo! Finance]
Structure Therapeutics Inc. (GPCR)
Company Research
Source: Yahoo! Finance
A copy of the same can be downloaded here . The fund advanced 7.69% (Institutional Shares) in the quarter compared to a 6.96% gain for the Russell 3000 Health Care Index and an 11.69% increase for the S&P 500 Index. For the full year, the fund increased 6.42%, compared to 2.87% and 26.29% returns for the indexes, respectively. In addition, please check the fund's top five holdings to know its best picks in 2023. Baron Health Care Fund featured stocks such as Structure Therapeutics Inc. (NASDAQ: GPCR ) in its Q4 2023 investor letter. Headquartered in South San Francisco, California, Structure Therapeutics Inc. (NASDAQ:GPCR) is a clinical stage global biopharmaceutical company. On January 19, 2024, Structure Therapeutics Inc. (NASDAQ:GPCR) stock closed at $40.77 per share. One-month return of Structure Therapeutics Inc. (NASDAQ:GPCR) was 14.55%, and year-to-date its shares gained 0.02% of their value. Structure Therapeutics Inc. (NASDAQ:GPCR) has a market capitalization of $1.891 bill
Show less
Read more
Impact Snapshot
Event Time:
GPCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GPCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GPCR alerts
High impacting Structure Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
GPCR
News
- Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.MarketBeat
- Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $65.00 price target on the stock.MarketBeat
- Structure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceGlobeNewswire
- Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsGlobeNewswire
GPCR
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEF
- 4/19/24 - Form 4
- GPCR's page on the SEC website